230
Participants
Start Date
June 30, 2012
Primary Completion Date
March 31, 2014
Study Completion Date
May 31, 2014
CLA (Clarithro+Lanso+Amoxi)
Tablets of oral administration administered to subjects randomized to this group twice daily for 10 days.
PLA (Panto+Levoflox+Azithro)
Tablets of oral administration to subjects randomized to this group once daily for 10 days.
Hospital Ángeles, Clínica Londres, Mexico City
UNKNOWN
Centro InmunoQ, Mexico City
UNKNOWN
Torre Mayo, Metepec, State of Mexico
UNKNOWN
Hospital Ángeles Metropolitano, Mexico City
UNKNOWN
Centro Médico ABC Observatorio, Mexico City
UNKNOWN
Asofarma de México S.A de C.V.
INDUSTRY